Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
11,910
Total Claims
$1.2M
Drug Cost
1,041
Beneficiaries
$1,146
Cost/Patient
Risk Score Breakdown 15/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-65%
Opioid rate vs peers
0.8% vs 2.2% avg
-19%
Cost per patient vs peers
$1,146 vs $1,411 avg
+9%
Brand preference vs peers
11.6% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
0.8%
Opioid Rate
92
Opioid Claims
$1,379
Opioid Cost
14.1%
Long-Acting Rate
Brand vs Generic
Brand: 1,365 claims · $915K
Generic: 10,438 claims · $274K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Sitagliptin Phosphate | 143 | $160K |
| Rivaroxaban | 62 | $74K |
| Dapagliflozin Propanediol | 63 | $62K |
| Dulaglutide | 32 | $54K |
| Apixaban | 46 | $49K |
| Canagliflozin | 25 | $43K |
| Empagliflozin | 35 | $33K |
| Insulin Detemir | 18 | $29K |
| Insulin Glargine,hum.Rec.Anlog | 31 | $26K |
| Budesonide/Formoterol Fumarate | 21 | $24K |
| Fluticasone/Umeclidin/Vilanter | 22 | $23K |
| Mirabegron | 24 | $23K |
| Linagliptin | 13 | $18K |
| Tirzepatide | 15 | $17K |
| Insulin Glargine,hum.Rec.Anlog | 18 | $15K |
Prescribing Profile
Patient Profile
75
Avg Age
73%
Female
1.35
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About